← Open Payments lookup

RACHEL MCCOY: Open Payments

NPI 1639884968 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$372 in 28 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $364 · 2025 $372

Food & beverage: $372
CompanyPaymentsAmount
ABBVIE INC.12$150
Lilly USA, LLC11$133
AstraZeneca Pharmaceuticals LP2$36
Novo Nordisk Inc2$36
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$16

Products named: MOUNJARO, VRAYLAR, QULIPTA, FARXIGA, Ozempic, LINZESS, UBRELVY, CAPLYTA.

Industry payments across MS — which companies pay providers there.